Four Decades for Justice
Nicole M. Peles has a broad litigation practice, with a particular focus on antitrust, including antitrust counseling, regulatory work and antitrust litigation.
Ms. Peles’s representative matters include:
- Representing Meta in putative class action and individual antitrust litigation filed throughout the country related to the multi‑billion‑dollar digital advertising industry, alleging anticompetitive conduct purportedly harming purchasers of digital advertising as well as media companies who sell digital advertising on their websites.
- Represented AerCap Holdings N.V. on antitrust issues in connection with its $30 billion acquisition of GE Capital Aviation Services;
- Represented Qualcomm in a suit filed by the Federal Trade Commission (“FTC”) in California federal court alleging violations of Section 5 of the FTC Act and seeking a permanent injunction against Qualcomm. In August 2020, in a complete defense victory for Qualcomm, the Ninth Circuit unanimously reversed the district court’s prior judgment and vacated a permanent, worldwide injunction that had prohibited several of Qualcomm’s core business practices.
- Represented Mylan N.V. on antitrust issues in connection with its $50 billion combination with Upjohn, Pfizer Inc.’s off-patent branded and generic established medicines business, to form Viatris Inc., a new global pharmaceutical company.
- Represented US Foods Holding Corp. on antitrust issues in connection with its $1.8 billion acquisition of five operating companies of Services Group of America, which closed in September 2019.
- Represented Grupo Villar Mir on antitrust issues in connection with its $3.1 billion merger with Globe Specialty Metals, Inc.
- Represented Merck and current and former officers and directors in a class action and in individual actions that were part of a multidistrict litigation in New Jersey federal court relating to Merck’s development and sale of Vioxx®, all of which settled in 2016, and in related shareholder derivative actions and an ERISA class action.
Ms. Peles was born in Berkeley, California. She received an A.B. degree in 2007 from Dartmouth College and a J.D. degree cum laude in 2010 from New York University, where she was an executive editor of the Law Review. After graduation, she served as a law clerk to Hon. Nancy F. Atlas of the United States District Court for the Southern District of Texas.
Ms. Peles joined Cravath as a summer associate in 2009 and rejoined Cravath’s legal staff in 2011. She is admitted to practice in the U.S. District Courts for the District of Columbia, Eastern District of New York and Southern District of New York. She is a member of the American Bar Association’s Antitrust Section.
Ms. Peles’s representative matters include:
- Representing Meta in putative class action and individual antitrust litigation filed throughout the country related to the multi‑billion‑dollar digital advertising industry, alleging anticompetitive conduct purportedly harming purchasers of digital advertising as well as media companies who sell digital advertising on their websites.
- Represented AerCap Holdings N.V. on antitrust issues in connection with its $30 billion acquisition of GE Capital Aviation Services;
- Represented Qualcomm in a suit filed by the Federal Trade Commission (“FTC”) in California federal court alleging violations of Section 5 of the FTC Act and seeking a permanent injunction against Qualcomm. In August 2020, in a complete defense victory for Qualcomm, the Ninth Circuit unanimously reversed the district court’s prior judgment and vacated a permanent, worldwide injunction that had prohibited several of Qualcomm’s core business practices.
- Represented Mylan N.V. on antitrust issues in connection with its $50 billion combination with Upjohn, Pfizer Inc.’s off-patent branded and generic established medicines business, to form Viatris Inc., a new global pharmaceutical company.
- Represented US Foods Holding Corp. on antitrust issues in connection with its $1.8 billion acquisition of five operating companies of Services Group of America, which closed in September 2019.
- Represented Grupo Villar Mir on antitrust issues in connection with its $3.1 billion merger with Globe Specialty Metals, Inc.
- Represented Merck and current and former officers and directors in a class action and in individual actions that were part of a multidistrict litigation in New Jersey federal court relating to Merck’s development and sale of Vioxx®, all of which settled in 2016, and in related shareholder derivative actions and an ERISA class action.
Ms. Peles was born in Berkeley, California. She received an A.B. degree in 2007 from Dartmouth College and a J.D. degree cum laude in 2010 from New York University, where she was an executive editor of the Law Review. After graduation, she served as a law clerk to Hon. Nancy F. Atlas of the United States District Court for the Southern District of Texas.
Ms. Peles joined Cravath as a summer associate in 2009 and rejoined Cravath’s legal staff in 2011. She is admitted to practice in the U.S. District Courts for the District of Columbia, Eastern District of New York and Southern District of New York. She is a member of the American Bar Association’s Antitrust Section.
Education
-
J.D., 2010, New York University School of Lawcum laude
-
A.B., 2007, Dartmouth College
Clerkships
- Hon. Nancy F. Atlas, U.S.D.C. for the Southern District of Texas
Admitted In
- New York
Deals & Cases
November 21, 2023
Martin Marietta’s $2.1 Billion Sale of its South Texas Cement and Related Concrete Operations to CRH plc
On November 21, 2023, Martin Marietta Materials, Inc. (“Martin Marietta”) announced that it has entered into a definitive agreement to sell its South Texas cement business and certain of its related concrete operations to CRH Americas Materials, Inc., a subsidiary of CRH plc, for $2.1 billion in cash. Cravath is representing Martin Marietta in connection with the transaction.
Deals & Cases
November 13, 2023
Altus Group’s Acquisition of SitusAMC’s Commercial Real Estate Valuation Services Business
On November 9, 2023, Altus Group Limited (“Altus Group”), a leading provider of asset and fund intelligence for commercial restate, announced it has signed a definitive agreement to acquire the commercial real estate valuation and advisory services business of Situs Group LLC (a SitusAMC Company) for $225 million in cash. Cravath is representing Altus Group in connection with the transaction.
Deals & Cases
October 16, 2023
Vista Outdoor’s $1.91 Billion Sale of its Sporting Products Business to CSG
On October 16, 2023, Vista Outdoor Inc. (“Vista Outdoor”), the parent company of 41 renowned brands that design, manufacture and market sporting and outdoor products to consumers around the globe, announced a definitive agreement to sell its Sporting Products business to Czechoslovak Group a.s. (“CSG”), a leading industrial technology holding company, for an enterprise value of $1.91 billion in an all-cash transaction. This transaction represents the next step in Vista Outdoor’s plan to split the company into separate entities. Cravath is representing Vista Outdoor in connection with the transaction.
Deals & Cases
October 02, 2023
Viatris’s $6.94 Billion in Announced Divestitures
On October 1, 2023, Viatris Inc. (“Viatris”), a global healthcare company, announced it has received an offer for the divestiture of substantially all of its Over-the-Counter (“OTC”) business, and has entered into definitive agreements to divest its Women’s Healthcare business, its Active Pharmaceutical Ingredient (“API”) business in India and commercialization rights in certain non-core markets that were acquired as part of the combination with Upjohn. The total transactions value, including Viatris’s 2022 divestiture of its biosimilars business, represents up to $6.94 billion of total gross proceeds. The estimated transaction value for the divestitures announced today is $3.6 billion, including gross consideration of up to approximately $2.17 billion for the divestiture of substantially all of its OTC business, and up to approximately $1.2 billion combined for the divestitures of its API and Women’s Healthcare businesses. Cravath is representing Viatris in connection with the transactions.
Deals & Cases
September 21, 2023
Cravath and A Better Childhood Win Appellate Victory for Children in NYC Foster Care
On September 19, 2023, the U.S. Court of Appeals for the Second Circuit vacated a district court’s order denying class certification to all children who are or will be in the custody of New York City’s foster care system. Cravath, working on a pro bono basis, represents the putative class alongside co‑counsel at A Better Childhood (“ABC”).
Activities & Publications
November 14, 2023
Maggie Segall Authors Chapter in Global Competition Review’s “Merger Remedies Guide – Fifth Edition”
Cravath partner Margaret T. Segall authored a chapter entitled “Merger Remedies in Dynamic Industries” in Global Competition Review’s “Merger Remedies Guide – Fifth Edition,” which was published on October 25, 2023. The chapter, co‑authored by practice area attorney Nicole M. Peles, reviewed the common types of merger remedies, the characteristics of dynamic industries and challenges posed for traditional merger remedies. The chapter considered the different approaches adopted by antitrust authorities in creating remedies in the technology and pharmaceutical sectors, two rapidly evolving dynamic industries.
Nicole M. Peles has a broad litigation practice, with a particular focus on antitrust, including antitrust counseling, regulatory work and antitrust litigation.
Ms. Peles’s representative matters include:
- Representing Meta in putative class action and individual antitrust litigation filed throughout the country related to the multi‑billion‑dollar digital advertising industry, alleging anticompetitive conduct purportedly harming purchasers of digital advertising as well as media companies who sell digital advertising on their websites.
- Represented AerCap Holdings N.V. on antitrust issues in connection with its $30 billion acquisition of GE Capital Aviation Services;
- Represented Qualcomm in a suit filed by the Federal Trade Commission (“FTC”) in California federal court alleging violations of Section 5 of the FTC Act and seeking a permanent injunction against Qualcomm. In August 2020, in a complete defense victory for Qualcomm, the Ninth Circuit unanimously reversed the district court’s prior judgment and vacated a permanent, worldwide injunction that had prohibited several of Qualcomm’s core business practices.
- Represented Mylan N.V. on antitrust issues in connection with its $50 billion combination with Upjohn, Pfizer Inc.’s off-patent branded and generic established medicines business, to form Viatris Inc., a new global pharmaceutical company.
- Represented US Foods Holding Corp. on antitrust issues in connection with its $1.8 billion acquisition of five operating companies of Services Group of America, which closed in September 2019.
- Represented Grupo Villar Mir on antitrust issues in connection with its $3.1 billion merger with Globe Specialty Metals, Inc.
- Represented Merck and current and former officers and directors in a class action and in individual actions that were part of a multidistrict litigation in New Jersey federal court relating to Merck’s development and sale of Vioxx®, all of which settled in 2016, and in related shareholder derivative actions and an ERISA class action.
Ms. Peles was born in Berkeley, California. She received an A.B. degree in 2007 from Dartmouth College and a J.D. degree cum laude in 2010 from New York University, where she was an executive editor of the Law Review. After graduation, she served as a law clerk to Hon. Nancy F. Atlas of the United States District Court for the Southern District of Texas.
Ms. Peles joined Cravath as a summer associate in 2009 and rejoined Cravath’s legal staff in 2011. She is admitted to practice in the U.S. District Courts for the District of Columbia, Eastern District of New York and Southern District of New York. She is a member of the American Bar Association’s Antitrust Section.
Ms. Peles’s representative matters include:
- Representing Meta in putative class action and individual antitrust litigation filed throughout the country related to the multi‑billion‑dollar digital advertising industry, alleging anticompetitive conduct purportedly harming purchasers of digital advertising as well as media companies who sell digital advertising on their websites.
- Represented AerCap Holdings N.V. on antitrust issues in connection with its $30 billion acquisition of GE Capital Aviation Services;
- Represented Qualcomm in a suit filed by the Federal Trade Commission (“FTC”) in California federal court alleging violations of Section 5 of the FTC Act and seeking a permanent injunction against Qualcomm. In August 2020, in a complete defense victory for Qualcomm, the Ninth Circuit unanimously reversed the district court’s prior judgment and vacated a permanent, worldwide injunction that had prohibited several of Qualcomm’s core business practices.
- Represented Mylan N.V. on antitrust issues in connection with its $50 billion combination with Upjohn, Pfizer Inc.’s off-patent branded and generic established medicines business, to form Viatris Inc., a new global pharmaceutical company.
- Represented US Foods Holding Corp. on antitrust issues in connection with its $1.8 billion acquisition of five operating companies of Services Group of America, which closed in September 2019.
- Represented Grupo Villar Mir on antitrust issues in connection with its $3.1 billion merger with Globe Specialty Metals, Inc.
- Represented Merck and current and former officers and directors in a class action and in individual actions that were part of a multidistrict litigation in New Jersey federal court relating to Merck’s development and sale of Vioxx®, all of which settled in 2016, and in related shareholder derivative actions and an ERISA class action.
Ms. Peles was born in Berkeley, California. She received an A.B. degree in 2007 from Dartmouth College and a J.D. degree cum laude in 2010 from New York University, where she was an executive editor of the Law Review. After graduation, she served as a law clerk to Hon. Nancy F. Atlas of the United States District Court for the Southern District of Texas.
Ms. Peles joined Cravath as a summer associate in 2009 and rejoined Cravath’s legal staff in 2011. She is admitted to practice in the U.S. District Courts for the District of Columbia, Eastern District of New York and Southern District of New York. She is a member of the American Bar Association’s Antitrust Section.
Education
-
J.D., 2010, New York University School of Lawcum laude
-
A.B., 2007, Dartmouth College
Clerkships
- Hon. Nancy F. Atlas, U.S.D.C. for the Southern District of Texas
Admitted In
- New York
Deals & Cases
November 21, 2023
Martin Marietta’s $2.1 Billion Sale of its South Texas Cement and Related Concrete Operations to CRH plc
On November 21, 2023, Martin Marietta Materials, Inc. (“Martin Marietta”) announced that it has entered into a definitive agreement to sell its South Texas cement business and certain of its related concrete operations to CRH Americas Materials, Inc., a subsidiary of CRH plc, for $2.1 billion in cash. Cravath is representing Martin Marietta in connection with the transaction.
Deals & Cases
November 13, 2023
Altus Group’s Acquisition of SitusAMC’s Commercial Real Estate Valuation Services Business
On November 9, 2023, Altus Group Limited (“Altus Group”), a leading provider of asset and fund intelligence for commercial restate, announced it has signed a definitive agreement to acquire the commercial real estate valuation and advisory services business of Situs Group LLC (a SitusAMC Company) for $225 million in cash. Cravath is representing Altus Group in connection with the transaction.
Deals & Cases
October 16, 2023
Vista Outdoor’s $1.91 Billion Sale of its Sporting Products Business to CSG
On October 16, 2023, Vista Outdoor Inc. (“Vista Outdoor”), the parent company of 41 renowned brands that design, manufacture and market sporting and outdoor products to consumers around the globe, announced a definitive agreement to sell its Sporting Products business to Czechoslovak Group a.s. (“CSG”), a leading industrial technology holding company, for an enterprise value of $1.91 billion in an all-cash transaction. This transaction represents the next step in Vista Outdoor’s plan to split the company into separate entities. Cravath is representing Vista Outdoor in connection with the transaction.
Deals & Cases
October 02, 2023
Viatris’s $6.94 Billion in Announced Divestitures
On October 1, 2023, Viatris Inc. (“Viatris”), a global healthcare company, announced it has received an offer for the divestiture of substantially all of its Over-the-Counter (“OTC”) business, and has entered into definitive agreements to divest its Women’s Healthcare business, its Active Pharmaceutical Ingredient (“API”) business in India and commercialization rights in certain non-core markets that were acquired as part of the combination with Upjohn. The total transactions value, including Viatris’s 2022 divestiture of its biosimilars business, represents up to $6.94 billion of total gross proceeds. The estimated transaction value for the divestitures announced today is $3.6 billion, including gross consideration of up to approximately $2.17 billion for the divestiture of substantially all of its OTC business, and up to approximately $1.2 billion combined for the divestitures of its API and Women’s Healthcare businesses. Cravath is representing Viatris in connection with the transactions.
Deals & Cases
September 21, 2023
Cravath and A Better Childhood Win Appellate Victory for Children in NYC Foster Care
On September 19, 2023, the U.S. Court of Appeals for the Second Circuit vacated a district court’s order denying class certification to all children who are or will be in the custody of New York City’s foster care system. Cravath, working on a pro bono basis, represents the putative class alongside co‑counsel at A Better Childhood (“ABC”).
Activities & Publications
November 14, 2023
Maggie Segall Authors Chapter in Global Competition Review’s “Merger Remedies Guide – Fifth Edition”
Cravath partner Margaret T. Segall authored a chapter entitled “Merger Remedies in Dynamic Industries” in Global Competition Review’s “Merger Remedies Guide – Fifth Edition,” which was published on October 25, 2023. The chapter, co‑authored by practice area attorney Nicole M. Peles, reviewed the common types of merger remedies, the characteristics of dynamic industries and challenges posed for traditional merger remedies. The chapter considered the different approaches adopted by antitrust authorities in creating remedies in the technology and pharmaceutical sectors, two rapidly evolving dynamic industries.
Cravath Bicentennial
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. © 2023 Cravath, Swaine & Moore LLP.